These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics. Farr G; Amatya R; Betancourt JD; David M; Alfonso L; Dacalos E Contraception; 1994 Nov; 50(5):417-29. PubMed ID: 7859451 [TBL] [Abstract][Full Text] [Related]
44. Comparative randomized study of the copper-T 200 and Dalkon Shield intrauterine devices. Spellacy WN; Birk SA; Gordon L Contraception; 1975 Oct; 12(4):453-63. PubMed ID: 1192734 [TBL] [Abstract][Full Text] [Related]
45. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion]. Jensen HH; Blaabjerg J; Lyndrup J Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090 [TBL] [Abstract][Full Text] [Related]
46. The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease. Kaufman DW; Watson J; Rosenberg L; Helmrich SP; Miller DR; Miettinen OS; Stolley PD; Shapiro S JAMA; 1983 Aug; 250(6):759-62. PubMed ID: 6876331 [TBL] [Abstract][Full Text] [Related]
51. Clinical experience with intrauterine devices in a private practice. Hasson HM Adv Contracept; 1985 Mar; 1(1):51-61. PubMed ID: 3842212 [TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Celen S; Möröy P; Sucak A; Aktulay A; Danişman N Contraception; 2004 Apr; 69(4):279-82. PubMed ID: 15033401 [TBL] [Abstract][Full Text] [Related]
53. [Use of modified intrauterine device (IUD) TCu 380 with chromium filaments in the immediate postpartum]. Hernández Valencia M; Becerril Flores LC Ginecol Obstet Mex; 2000 Feb; 68():70-6. PubMed ID: 10774108 [TBL] [Abstract][Full Text] [Related]
54. The intrauterine device today. Rioux JE J SOGC; 1993 Oct; 15(8):921-4. PubMed ID: 12318529 [TBL] [Abstract][Full Text] [Related]
55. The Dalkon Shield. FDA Consum; 1975 Feb; 9(1):21. PubMed ID: 10308671 [TBL] [Abstract][Full Text] [Related]
56. Four years of experience with the TCu 380A intrauterine contraceptive device. Sivin I; Tatum HJ Fertil Steril; 1981 Aug; 36(2):159-63. PubMed ID: 7262334 [TBL] [Abstract][Full Text] [Related]
57. Menstrual problems and side effects associated with long-term TCu 380A IUD use in perimenopausal women. Reinprayoon D; Taneepanichskul S Contraception; 1998 Jun; 57(6):417-9. PubMed ID: 9693403 [TBL] [Abstract][Full Text] [Related]
58. An association between the Dalkon Shield and complicated pregnancies among women hospitalized for intrauterine contraceptive device--related disorders. Kahn HS; Tyler CW Am J Obstet Gynecol; 1976 May; 125(1):83-6. PubMed ID: 1275008 [TBL] [Abstract][Full Text] [Related]
59. Medical records in litigation: the Dalkon Shield story. Byrne K AMRO; 1992 Feb; 32(5):11-4. PubMed ID: 10117045 [TBL] [Abstract][Full Text] [Related]
60. Long-term use of intrauterine contraceptive devices in a private practice. Sandmire HF; Cavanaugh RA Am J Obstet Gynecol; 1985 May; 152(2):169-75. PubMed ID: 3923835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]